JANSSEN-CILAG A/S: Financial statements 2020
CVR: 19248615
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
JANSSEN-CILAG A/S (CVR 19248615) has filed annual accounts for 2020. In 2020, the company reported revenue of DKK 1,304,814,000 and a net result of DKK 56,374,000 compared with DKK 54,767,000 the year before. That is an increase of 9.2% compared with the year before. The profit margin was 4.3%. Equity in the 2020 report amounted to DKK 132,781,000. The solvency ratio was 29.7%. The company had 116 employees in the financial year.
- Revenue
- DKK 1,304,814,000
- Gross Profit
- DKK 270,376,000
- Profit/Loss
- DKK 56,374,000
- Equity
- DKK 132,781,000
- Total Assets
- DKK 446,744,000
- Employees
- 116
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | 1.3B | 270.4M | 56.4M | 132.8M | 116 |
| 2019 | 1.2B | 273.7M | 54.8M | 126.4M | 115 |
| 2018 | 1.2B | 275.1M | 60.5M | 375.4M | 106 |
| 2017 | 968.1M | 236.1M | 37.1M | 314.9M | 116 |
| 2016 | 834.7M | 261.5M | 59.6M | 277.9M | 107 |
Official annual report
How creditworthy is JANSSEN-CILAG A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
As of December 1, 2020, Timothy James House has joined the board of directors of JANSSEN-CILAG A/S.
As of December 1, 2020, Jesús Morcillo Garcia has left the board of directors of JANSSEN-CILAG A/S.
JANSSEN-CILAG A/S has published its annual report for 2019. Revenue came to DKK 1,194,701,000, and the net result was DKK 54,767,000.
As of April 30, 2020, Julie Enevold Brooker has joined the board of directors of JANSSEN-CILAG A/S.
As of April 30, 2020, Tina Buhl has left the board of directors of JANSSEN-CILAG A/S.
About JANSSEN-CILAG A/S
JANSSEN-CILAG A/S is a Danish company of the type Aktieselskab based in København Ø, founded in 1969. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named JANSSENPHARMA A/S. The management consists of Mario Klesse. The board consists of Philipp Christian Hellweg (chair), Liana Akhmetzhanova, Mario Klesse and Nevret Mahmudovski. The company is owned by Janssen Cilag AB. The company has 116 employees (2026). In 2025, the company reported revenue of DKK 1,442,304,000 and a net result of DKK 43,183,000 compared with DKK 64,466,000 the year before. Equity in the 2025 report amounted to DKK 216,425,000.